The US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for brensocatib for patients with ...

Nearly one year after winning an FDA drug approval to treat an ultra-rare disease, X4 Pharmaceuticals is making layoffs that ...

VolitionRx Limited Volition a multi-national epigenetics company, announces its first commercial sale of Volition's High Throughput Synthetic Sepsis method that measures Neutrophil Extracellular Traps ...

ALL of us would like to live a healthy life for as long as possible and many tend to assume that life expectancy is largely ...

The Masked Singer judge, who recently underwent surgery for a brain tumour, was told the top five things you can do to slow ...

Testosterone worsens the damage caused by a heart attack by increasing the number of white blood cells released from the bone marrow. This is shown ...

The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 4 February 2025, approved the vaccine chikungunya vaccine (live) (brand name ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the ...

A new study conducted in mice suggests that, although it's not all good, our urge to scratch at itchy skin may have an evolutionary benefit.

Rapidly spreading, harrowing and potentially lethal, a necrotizing soft tissue infection — so-called flesh-eating disease — ...